Gilead Statement on Uganda's Anti-Homosexuality Act

Foster City, Calif., April 6, 2024 – Gilead Sciences is resolute in our commitment to LGBTQ+ communities and to help end the HIV epidemic for everyone, everywhere. We strongly oppose the Anti-Homosexuality Act in Uganda and are deeply disappointed by the recent ruling upholding the criminalization of LGBTQ+ communities.

We stand with LGBTQ+ communities in Uganda and around the world who continue to fight oppressive laws that drive inequity and endanger lives. We know criminalization of LGBTQ+ communities drives the stigma and discrimination that fuel epidemics like HIV.

This disregard for human rights jeopardizes progress made in the fight against HIV and the essential work of dedicated healthcare providers serving communities most in need.

About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.